PancrImmune

Pancreatic cancer has the worst survival of any human cancer, and tumours are known to be extremely aggressive with minimal response to conventional systemic therapy.

In 2019, Dr Rachael Bashford-Rogers and Dr Shivan Sivakumar launched PancrImmune: the Oxford Pancreatic Network, which brings together the experimental, clinical and statistical expertise from across the Oxford ecosystem to investigate the immune microenvironment of pancreatic pathologies and plan novel therapeutic strategies for improving patient outcome.

Across the network, there are researchers and clinicians pioneering work across 12 core themes to truly understand the pancreas, how it causes such significant but varying diseases, and unlock the potential to treat pancreatic cancer.

For updates on the research and clinical trial outcomes of this work, please see the news section of the website.

PancrImmune is funded by grants including the Wellcome Trust.

Through focusing on 12 core themes in pancreatic biology, the Oxford Pancreatic Network aims to publish world-leading, high-impact research that will produce novel trials that can change the outcome of pancreatic diseases.

Network Team

PancrImmune includes researchers and clinicians from across the University departments, focusing on 12 core themes.

The network is coordinated and lead by a core team, read more about each of their work through the profiles below.

Shivan Sivakumar

Shivan Sivakumar

Rachael Bashford-Rogers

Rachael Bashford-Rogers

Enas Abu-Shah

Enas Abu-Shah

Mark Middleton

Mark Middleton

Somnath Mukherjee

Somnath Mukherjee

Eric O’Neill

Eric O’Neill

Michael Dustin

Michael Dustin

Constantin Coussios

Constantin Coussios

Siim Pauklin

Siim Pauklin

Kate Lines

Kate Lines

Raj Thakker

Raj Thakker

John Todd

John Todd

Emma Culver

Emma Culver

Gillian Farnie

Gillian Farnie

Keaton Jones

Keaton Jones

A full list of members currently participating in collaborative pancreatic projects in Oxford